318 results on '"Rasola, Andrea"'
Search Results
2. Zebrafish polg2 knock-out recapitulates human POLG-disorders; implications for drug treatment
3. Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
4. The mitochondrial chaperone TRAP1 regulates F-ATP synthase channel formation
5. Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3
6. The Use of Hexokinase 2-Displacing Peptides as an Anti-Neoplastic Approach for Malignant Peripheral Nerve Sheath Tumors.
7. Metabolic Features of Neurofibromatosis Type 1-Associated Tumors
8. Design of Allosteric Stimulators of the Hsp90 ATPase as New Anticancer Leads
9. Defining the molecular mechanisms of the mitochondrial permeability transition through genetic manipulation of F-ATP synthase
10. GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop
11. HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia
12. Efficient clofilium tosylate-mediated rescue of POLG-related disease phenotypes in zebrafish
13. Chaperones and protein quality control in the neoplastic process
14. Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
15. Supplementary figures legends from S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase
16. Data from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
17. Figure S6 from S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase
18. Supplementary Table S1 from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
19. Supplementary table 1 from S-nitrosylation of the Mitochondrial Chaperone TRAP1 Sensitizes Hepatocellular Carcinoma Cells to Inhibitors of Succinate Dehydrogenase
20. Supplementary Figures S1-S9 from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
21. Supplementary Materials and Methods from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
22. Supplementary Figure Legends from VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
23. The N-terminus of Cyclophilin D modulates its binding to ATP synthase
24. Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes
25. Nitric oxide-based regulation of metabolism: Hints from TRAP1 and SIRT3 crosstalk
26. Plasma small‐extracellular vesicles enriched in miR‐122‐5p promote disease aggressiveness in pediatric anaplastic large‐cell lymphoma.
27. MAPK15 protects from oxidative stress‐dependent cellular senescence by inducing the mitophagic process
28. The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
29. Unraveling the role of mitochondrial metabolism in tumors of the peripheral nervous system
30. Metabolic Features of Neurofibromatosis Type 1-Associated Tumors
31. Activation of Mitochondrial ERK Protects Cancer Cells from Death through Inhibition of the Permeability Transition
32. Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons
33. TRAP1 and cyclophilin D compete at OSCP subunit to regulate enzymatic activity and permeability transition pore opening by F-ATP synthase
34. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting
35. Signal transduction to the permeability transition pore
36. SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern
37. Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives
38. Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer
39. Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3
40. Neurofibromin Deficiency and Extracellular Matrix Cooperate to Increase Transforming Potential through FAK-Dependent Signaling
41. Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters
42. Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma
43. Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+and SIRT3
44. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1
45. Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells
46. Analysis of the Effects of Hexokinase 2 Detachment From Mitochondria-Associated Membranes with the Highly Selective Peptide HK2pep
47. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis
48. Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1
49. A glutamine synthetase inhibitor increases survival and decreases cytokine response in a mouse model of acute liver failure
50. HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.